The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected in a Patient With T-Lymphoblastic Leukemia/Lymphoma and T(7;8)(q22;p11)
Haematologica- Italy
doi 10.3324/haematol.2010.036558
Full Text
Abstract
Available in
Categories
Date
February 17, 2011
Authors
Publisher
Ferrata Storti Foundation (Haematologica)